ResMed Launches Sleep Apnoea Device in U.S.

June 18, 2012
ResMed has launched Narval CC, a medical device to treat snoring and obstructive sleep apnoea, in U.S. The respiratory device company will provide Narval CC to U.S. patients as an alternative to PAP therapy for snoring and more moderate cases of sleep apnoea.
Australian Life Scientist